{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:20:56Z","timestamp":1791411656597,"version":"4.3.3"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1093\/jac\/dkv491","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T20:59:14Z","timestamp":1454360354000},"page":"1386-1394","source":"Crossref","is-referenced-by-count":28,"title":["A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study"],"prefix":"10.1093","volume":"71","author":[{"given":"Alexandre","family":"Brasseur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Hites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Roisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,31]]},"reference":[{"key":"2016041309202595000_71.5.1386.1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.10.1353"},{"key":"2016041309202595000_71.5.1386.2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819ced02"},{"key":"2016041309202595000_71.5.1386.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.12.012"},{"key":"2016041309202595000_71.5.1386.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.08.006"},{"key":"2016041309202595000_71.5.1386.5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MCC.0b013e32827851d7","article-title":"Old antibiotics for infections in critically ill patients","volume":"13","author":"Falagas","year":"2003","journal-title":"Curr Opin Crit Care"},{"key":"2016041309202595000_71.5.1386.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01108-9"},{"key":"2016041309202595000_71.5.1386.7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181eb3ccd"},{"key":"2016041309202595000_71.5.1386.8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.1.93"},{"key":"2016041309202595000_71.5.1386.9","doi-asserted-by":"publisher","DOI":"10.1186\/cc8945"},{"key":"2016041309202595000_71.5.1386.10","doi-asserted-by":"publisher","DOI":"10.1086\/520991"},{"key":"2016041309202595000_71.5.1386.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0850-8"},{"key":"2016041309202595000_71.5.1386.12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00441-10"},{"key":"2016041309202595000_71.5.1386.13","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"2016041309202595000_71.5.1386.14","unstructured":"EUCAST. Aminoglycosides: EUCAST Clinical MIC Breakpoints . http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_4.0.pdf ."},{"key":"2016041309202595000_71.5.1386.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"2016041309202595000_71.5.1386.16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.43.3.623","article-title":"Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria","volume":"43","author":"Kashuba","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2016041309202595000_71.5.1386.17","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90137-6"},{"key":"2016041309202595000_71.5.1386.18","doi-asserted-by":"publisher","DOI":"10.1007\/BF01694773"},{"key":"2016041309202595000_71.5.1386.19","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198608000-00028"},{"key":"2016041309202595000_71.5.1386.20","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709751"},{"key":"2016041309202595000_71.5.1386.21","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"2016041309202595000_71.5.1386.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.03.022"},{"key":"2016041309202595000_71.5.1386.23","doi-asserted-by":"publisher","DOI":"10.1186\/cc12844"},{"key":"2016041309202595000_71.5.1386.24","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181961bff"},{"key":"2016041309202595000_71.5.1386.25","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31818b6b2f"},{"key":"2016041309202595000_71.5.1386.26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2016041309202595000_71.5.1386.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.01.026"},{"key":"2016041309202595000_71.5.1386.28","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-13-14"},{"key":"2016041309202595000_71.5.1386.29","doi-asserted-by":"publisher","DOI":"10.1186\/cc9415"},{"key":"2016041309202595000_71.5.1386.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902413"},{"key":"2016041309202595000_71.5.1386.31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.464"},{"key":"2016041309202595000_71.5.1386.32","doi-asserted-by":"publisher","DOI":"10.1179\/1120009X12Z.0000000006"},{"key":"2016041309202595000_71.5.1386.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3719-z"},{"key":"2016041309202595000_71.5.1386.34","doi-asserted-by":"publisher","DOI":"10.1086\/599225"},{"key":"2016041309202595000_71.5.1386.35","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-1-30"},{"key":"2016041309202595000_71.5.1386.36","first-page":"463","article-title":"A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Ni","year":"2014","journal-title":"Pak J Pharm Sci"},{"key":"2016041309202595000_71.5.1386.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.05.018"},{"key":"2016041309202595000_71.5.1386.38","doi-asserted-by":"publisher","DOI":"10.1186\/cc13858"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/5\/1386\/11281707\/dkv491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T01:35:57Z","timestamp":1567560957000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,31]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,13]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1093\/jac\/dkv491"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv491","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,31]]}}}